Page last updated: 2024-12-10

agathisflavone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

agathisflavone: bis-apigenin coupled at 6 and 8 positions; isolated from the plant Canarium manii; has hepatoprotective activity against carbon tetrachloride-induced hepatotoxicity [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

agathisflavone : A biflavonoid that is obtained by oxidative coupling of two molecules of apigenin resulting in a bond between positions C-6 and C-8 of the two chromene rings. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

FloraRankFlora DefinitionFamilyFamily Definition
Canariumgenus[no description available]BurseraceaeA plant family of the order Sapindales, subclass Rosidae, class Magnoliopsida. They are resinous trees and shrubs with alternate leaves composed of many leaflets.[MeSH]

Cross-References

ID SourceID
PubMed CID5281599
CHEMBL ID65320
CHEBI ID2512
SCHEMBL ID616142
MeSH IDM0211995

Synonyms (21)

Synonym
5,5',7,7'-tetrahydroxy-2,2'-bis(4-hydroxyphenyl)-6,8'-bichromene-4,4'-dione
5,5',7,7'-tetrahydroxy-2,2'-bis(4-hydroxyphenyl)-(6,8'-bi-4h-1-benzopyran)-4,4'-dione
CHEBI:2512 ,
28441-98-7
6,8''-biapigenin
C10017
agathisflavone
8-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-chromen-6-yl]-5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one
(6,8'-bi-4h-1-benzopyran)-4,4'-dione, 5,5',7,7'-tetrahydroxy-2,2'-bis(4-hydroxyphenyl)-
LMPK12040008
CHEMBL65320
8-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-6-yl]-5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one
7''-methyl-agathisflavone
SCHEMBL616142
DTXSID30182641
bdbm50478418
ncgc00384551-01!8-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-6-yl]-5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one
Q27105695
HY-118383
CS-0065801
AKOS040745510

Research Excerpts

Overview

Agathisflavone is a flavonoid studied in neurodegenerative diseases and cancer. It is a bioactive compound in Anacardium occidentale.

ExcerptReferenceRelevance
"Agathisflavone is a flavonoid studied in neurodegenerative diseases and cancer."( Reverted effect of mesenchymal stem cells in glioblastoma treated with agathisflavone and its selective antitumoral effect on cell viability, migration, and differentiation via STAT3.
Amaral da Silva, VD; Costa, SL; da Silva, KC; David, JM; David, JP; de Faria Lopes, GP; de Fátima Costa, M; Dos Santos, BL; Moura-Neto, V; Nascimento, RP; Oliveira, MDN; Ulrich, H, 2021
)
1.58
"Agathisflavone is a bioactive compound in Anacardium occidentale. "( Agathisflavone isolated from Anacardium occidentale suppresses SIRT1-mediated neuroinflammation in BV2 microglia and neurotoxicity in APPSwe-transfected SH-SY5Y cells.
Aderogba, MA; Ajileye, OO; Jain, P; Okorji, U; Olajide, OA; Velagapudi, R, 2018
)
3.37

Treatment

ExcerptReferenceRelevance
"Treatment with agathisflavone (1 μM) decreased astroglial GFAP expression and hypertrophy and induced an increase in the number of neurons and neurite outgrowth into the lesion site."( Agathisflavone modulates astrocytic responses and increases the population of neurons in an in vitro model of traumatic brain injury.
Butt, AM; Costa, SL; da Silva, AB; da Silva, VDA; David, JM; David, JPL; de Amorim, VCM; de Fátima Dias Costa, M; Júnior, MSO, 2020
)
2.34
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (4)

RoleDescription
antineoplastic agentA substance that inhibits or prevents the proliferation of neoplasms.
antiviral agentA substance that destroys or inhibits replication of viruses.
hepatoprotective agentAny compound that is able to prevent damage to the liver.
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
biflavonoidA flavonoid oligomer that is obtained by the oxidative coupling of at least two units of aryl-substituted benzopyran rings or its substituted derivatives, resulting in the two ring systems being joined together by a single atom or bond.
hydroxyflavoneAny flavone in which one or more ring hydrogens are replaced by hydroxy groups.
biarylAn organic aromatic compound whose structure contains two aromatic rings or ring systems, joined to each other by a single bond.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (3)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Cystathionine gamma-lyaseHomo sapiens (human)IC50 (µMol)400.00000.57002.86098.0000AID1506495
Cystathionine beta-synthaseHomo sapiens (human)IC50 (µMol)17.10001.00005.15718.9000AID1506494
Reverse transcriptase/RNaseH Human immunodeficiency virus 1IC50 (µMol)100.00000.00011.076810.0000AID355251
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (32)

Processvia Protein(s)Taxonomy
cysteine metabolic processCystathionine gamma-lyaseHomo sapiens (human)
lipid metabolic processCystathionine gamma-lyaseHomo sapiens (human)
protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysineCystathionine gamma-lyaseHomo sapiens (human)
cysteine biosynthetic process via cystathionineCystathionine gamma-lyaseHomo sapiens (human)
cysteine biosynthetic processCystathionine gamma-lyaseHomo sapiens (human)
transsulfurationCystathionine gamma-lyaseHomo sapiens (human)
endoplasmic reticulum unfolded protein responseCystathionine gamma-lyaseHomo sapiens (human)
positive regulation of canonical NF-kappaB signal transductionCystathionine gamma-lyaseHomo sapiens (human)
protein sulfhydrationCystathionine gamma-lyaseHomo sapiens (human)
protein homotetramerizationCystathionine gamma-lyaseHomo sapiens (human)
hydrogen sulfide biosynthetic processCystathionine gamma-lyaseHomo sapiens (human)
positive regulation of aortic smooth muscle cell differentiationCystathionine gamma-lyaseHomo sapiens (human)
cellular response to leukemia inhibitory factorCystathionine gamma-lyaseHomo sapiens (human)
negative regulation of apoptotic signaling pathwayCystathionine gamma-lyaseHomo sapiens (human)
endochondral ossificationCystathionine beta-synthaseHomo sapiens (human)
blood vessel remodelingCystathionine beta-synthaseHomo sapiens (human)
L-serine metabolic processCystathionine beta-synthaseHomo sapiens (human)
L-serine catabolic processCystathionine beta-synthaseHomo sapiens (human)
superoxide metabolic processCystathionine beta-synthaseHomo sapiens (human)
regulation of nitric oxide mediated signal transductionCystathionine beta-synthaseHomo sapiens (human)
cysteine biosynthetic process via cystathionineCystathionine beta-synthaseHomo sapiens (human)
cysteine biosynthetic processCystathionine beta-synthaseHomo sapiens (human)
transsulfurationCystathionine beta-synthaseHomo sapiens (human)
L-cysteine catabolic processCystathionine beta-synthaseHomo sapiens (human)
cerebellum morphogenesisCystathionine beta-synthaseHomo sapiens (human)
DNA protectionCystathionine beta-synthaseHomo sapiens (human)
negative regulation of apoptotic processCystathionine beta-synthaseHomo sapiens (human)
homocysteine catabolic processCystathionine beta-synthaseHomo sapiens (human)
homocysteine metabolic processCystathionine beta-synthaseHomo sapiens (human)
response to folic acidCystathionine beta-synthaseHomo sapiens (human)
maternal process involved in female pregnancyCystathionine beta-synthaseHomo sapiens (human)
cartilage development involved in endochondral bone morphogenesisCystathionine beta-synthaseHomo sapiens (human)
hydrogen sulfide biosynthetic processCystathionine beta-synthaseHomo sapiens (human)
cellular response to hypoxiaCystathionine beta-synthaseHomo sapiens (human)
blood vessel diameter maintenanceCystathionine beta-synthaseHomo sapiens (human)
cysteine biosynthetic process from serineCystathionine beta-synthaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (21)

Processvia Protein(s)Taxonomy
cystathionine gamma-lyase activityCystathionine gamma-lyaseHomo sapiens (human)
protein bindingCystathionine gamma-lyaseHomo sapiens (human)
calmodulin bindingCystathionine gamma-lyaseHomo sapiens (human)
pyridoxal phosphate bindingCystathionine gamma-lyaseHomo sapiens (human)
identical protein bindingCystathionine gamma-lyaseHomo sapiens (human)
L-cystine L-cysteine-lyase (deaminating)Cystathionine gamma-lyaseHomo sapiens (human)
homocysteine desulfhydrase activityCystathionine gamma-lyaseHomo sapiens (human)
L-cysteine desulfhydrase activityCystathionine gamma-lyaseHomo sapiens (human)
selenocystathionine gamma-lyase activityCystathionine gamma-lyaseHomo sapiens (human)
cystathionine beta-synthase activityCystathionine beta-synthaseHomo sapiens (human)
protein bindingCystathionine beta-synthaseHomo sapiens (human)
oxygen bindingCystathionine beta-synthaseHomo sapiens (human)
enzyme bindingCystathionine beta-synthaseHomo sapiens (human)
heme bindingCystathionine beta-synthaseHomo sapiens (human)
pyridoxal phosphate bindingCystathionine beta-synthaseHomo sapiens (human)
ubiquitin protein ligase bindingCystathionine beta-synthaseHomo sapiens (human)
identical protein bindingCystathionine beta-synthaseHomo sapiens (human)
protein homodimerization activityCystathionine beta-synthaseHomo sapiens (human)
metal ion bindingCystathionine beta-synthaseHomo sapiens (human)
nitrite reductase (NO-forming) activityCystathionine beta-synthaseHomo sapiens (human)
carbon monoxide bindingCystathionine beta-synthaseHomo sapiens (human)
nitric oxide bindingCystathionine beta-synthaseHomo sapiens (human)
modified amino acid bindingCystathionine beta-synthaseHomo sapiens (human)
S-adenosyl-L-methionine bindingCystathionine beta-synthaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (4)

Processvia Protein(s)Taxonomy
cytosolCystathionine gamma-lyaseHomo sapiens (human)
extracellular exosomeCystathionine gamma-lyaseHomo sapiens (human)
cytoplasmCystathionine gamma-lyaseHomo sapiens (human)
nucleusCystathionine beta-synthaseHomo sapiens (human)
cytoplasmCystathionine beta-synthaseHomo sapiens (human)
cytosolCystathionine beta-synthaseHomo sapiens (human)
cytoplasmCystathionine beta-synthaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (15)

Assay IDTitleYearJournalArticle
AID355251Inhibition of HIV1 recombinant reverse transcriptase p66/p51 expressed in Escherichia coli1997Journal of natural products, Sep, Volume: 60, Issue:9
In vitro anti-HIV activity of biflavonoids isolated from Rhus succedanea and Garcinia multiflora.
AID1190380Inhibition of dengue virus 2 NS2B-NS3 serine protease assessed as reduction in hydrolysis of Boc-Gly-Arg-Arg-7-amino-4-methylcumarin substrate2015Bioorganic & medicinal chemistry, Feb-01, Volume: 23, Issue:3
Flavonoids as noncompetitive inhibitors of Dengue virus NS2B-NS3 protease: inhibition kinetics and docking studies.
AID1506497Reversible inhibition of full-length GST-fused human CBS using cysteine/homocysteine as substrate assessed as decrease in H2S production at 100 uM preincubated for 1 hr followed by ultrafiltration for 5 times2017MedChemComm, Jan-01, Volume: 8, Issue:1
Discovery of selective cystathionine β-synthase inhibitors by high-throughput screening with a fluorescent thiol probe.
AID1551061Displacement of [3H]-Flumazenil from GABAA/BZD receptor in Sprague-Dawley rat cerebral cortex incubated for 40 mins by liquid scintillation counting method2019European journal of medicinal chemistry, Jun-01, Volume: 171GABA allosteric modulators: An overview of recent developments in non-benzodiazepine modulators.
AID1506494Inhibition of full-length GST-fused human CBS using cysteine/homocysteine as substrate assessed as decrease in H2S production preincubated for 3 mins in presence of homocysteine and lead nitrate followed by cysteine addition2017MedChemComm, Jan-01, Volume: 8, Issue:1
Discovery of selective cystathionine β-synthase inhibitors by high-throughput screening with a fluorescent thiol probe.
AID355252Inhibition of HIV1 recombinant reverse transcriptase p66/p51 expressed in Escherichia coli at 200 ug/mL1997Journal of natural products, Sep, Volume: 60, Issue:9
In vitro anti-HIV activity of biflavonoids isolated from Rhus succedanea and Garcinia multiflora.
AID1190383Inhibition of dengue virus 3 NS2B-NS3 serine protease assessed as reduction in hydrolysis of Boc-Gly-Arg-Arg-7-amino-4-methylcumarin substrate2015Bioorganic & medicinal chemistry, Feb-01, Volume: 23, Issue:3
Flavonoids as noncompetitive inhibitors of Dengue virus NS2B-NS3 protease: inhibition kinetics and docking studies.
AID355254Cytotoxicity against uninfected PHA-stimulated human PBMC assessed as thymidine incorporation after 24 hrs by trypan blue exclusion method1997Journal of natural products, Sep, Volume: 60, Issue:9
In vitro anti-HIV activity of biflavonoids isolated from Rhus succedanea and Garcinia multiflora.
AID1506498Antiproliferative activity against human HT-29 cells assessed as decrease in cell viability after 24 hrs by CCK8 assay2017MedChemComm, Jan-01, Volume: 8, Issue:1
Discovery of selective cystathionine β-synthase inhibitors by high-throughput screening with a fluorescent thiol probe.
AID1190382Non-competitive inhibition of dengue virus 2 NS2B-NS3 serine protease assessed as reduction in hydrolysis of Boc-Gly-Arg-Arg-7-amino-4-methylcumarin substrate by Lineweaver-Burk plot and Dixon plot2015Bioorganic & medicinal chemistry, Feb-01, Volume: 23, Issue:3
Flavonoids as noncompetitive inhibitors of Dengue virus NS2B-NS3 protease: inhibition kinetics and docking studies.
AID355255Selectivity index, ratio of IC50 for human PBMC to EC50 for HIV1 LAV-11997Journal of natural products, Sep, Volume: 60, Issue:9
In vitro anti-HIV activity of biflavonoids isolated from Rhus succedanea and Garcinia multiflora.
AID355253Antiviral activity against HIV1 LAV-1 in PHA-stimulated human PBMC after 6 days1997Journal of natural products, Sep, Volume: 60, Issue:9
In vitro anti-HIV activity of biflavonoids isolated from Rhus succedanea and Garcinia multiflora.
AID144729Antituberculosis activity against Mycobacterium tuberculosis at a concentration of 12.5 ug/mL2001Bioorganic & medicinal chemistry letters, Aug-20, Volume: 11, Issue:16
Biflavonoids as novel antituberculosis agents.
AID1506495Inhibition of N-terminal His-tagged CSE extracted from human HepG2 cells expressed in Escherichia coli BL21 (DE3) using cysteine as substrate assessed as decrease in H2S production preincubated for 3 mins in presence of lead nitrate followed by cysteine a2017MedChemComm, Jan-01, Volume: 8, Issue:1
Discovery of selective cystathionine β-synthase inhibitors by high-throughput screening with a fluorescent thiol probe.
AID1190384Inhibition of dengue virus 3 NS2B-NS3 serine protease assessed as reduction in hydrolysis of Boc-Gly-Arg-Arg-7-amino-4-methylcumarin substrate by Dixon plot2015Bioorganic & medicinal chemistry, Feb-01, Volume: 23, Issue:3
Flavonoids as noncompetitive inhibitors of Dengue virus NS2B-NS3 protease: inhibition kinetics and docking studies.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (29)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (6.90)18.2507
2000's3 (10.34)29.6817
2010's17 (58.62)24.3611
2020's7 (24.14)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 23.72

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index23.72 (24.57)
Research Supply Index3.43 (2.92)
Research Growth Index5.51 (4.65)
Search Engine Demand Index23.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (23.72)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (10.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other27 (90.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]